Hepatocyte delivery of miR-34b/c reduces hepatic stellate cell activation and improves liver fibrosis
Open Access
- 9 June 2025
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 36 (3) , 102593
Abstract
No abstract availableKeywords
Funding Information
- Alpha Foundation for the Improvement of Mine Safety and Health
- Alpha-1 Foundation
- European Commission
- Fondazione Telethon
- PSC Partners Seeking a Cure
- Polo delle Scienze e delle Tecnologie per la Vita, Università degli Studi di Napoli Federico II
- FP7 Coordination of Research Activities (PNRR-MR1-2022-12376412)
This publication has 57 references indexed in Scilit:
- Inverse zonation of hepatocyte transduction with AAV vectors between mice and non-human primatesMolecular Genetics and Metabolism, 2011
- The rno‐miR‐34 family is upregulated and targets ACSL1 in dimethylnitrosamine‐induced hepatic fibrosis in ratsThe FEBS Journal, 2011
- The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 FamiliesPLOS ONE, 2011
- Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosisHepatology, 2010
- Epigenetic Control of MicroRNA Expression and AgingCurrent Genomics, 2009
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Ursodeoxycholic acid aggravates bile infarcts in bile duct–ligated and Mdr2 knockout mice via disruption of cholangiolesGastroenterology, 2002
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis.1994
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseaseCell, 1993